Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Cash & Equivalents (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed Cash & Equivalents for 16 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 504.55% year-over-year to $3.2 million, compared with a TTM value of $3.2 million through Dec 2025, up 504.55%, and an annual FY2025 reading of $3.2 million, up 504.55% over the prior year.
  • Cash & Equivalents was $3.2 million for Q4 2025 at InfuSystem Holdings, up from $955000.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.2 million in Q4 2025 and bottomed at $134000.0 in Q2 2023.
  • Average Cash & Equivalents over 5 years is $677200.0, with a median of $337000.0 recorded in 2022.
  • Peak annual rise in Cash & Equivalents hit 805.25% in 2021, while the deepest fall reached 98.07% in 2021.
  • Year by year, Cash & Equivalents stood at $186000.0 in 2021, then dropped by 11.29% to $165000.0 in 2022, then soared by 40.0% to $231000.0 in 2023, then surged by 128.14% to $527000.0 in 2024, then skyrocketed by 504.55% to $3.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for INFU at $3.2 million in Q4 2025, $955000.0 in Q3 2025, and $720000.0 in Q2 2025.